Q2 2022 Holdings
Filed 2022-08-12 | 13 holdings | $25.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $21.0M | 6,398,250 | 83.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $4.2M | 466,200 | 16.7% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $26.9K | 8,282,204 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $9.9K | 715,880 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $7.0K | 527,150 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $4.2K | 4,243,293 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $4.1K | 61,200 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $3.1K | 726,200 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $3.1K | 2,664,400 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $2.7K | 178,500 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $2.1K | 269,253 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $779 | 1,001,800 | 0.0% |
| Neximmune Inc | COM | 65344D109 | $215 | 133,442 | 0.0% |